WELLNESS BY DESIGN Trademark

Trademark Overview


On Wednesday, March 30, 2022, a trademark application was filed for WELLNESS BY DESIGN with the United States Patent and Trademark Office. The USPTO has given the WELLNESS BY DESIGN trademark a serial number of 97339107. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Thursday, September 12, 2024. This trademark is owned by Fig Life Sciences LLC. The WELLNESS BY DESIGN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of thrombosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical prepar...
wellness by design

General Information


Serial Number97339107
Word MarkWELLNESS BY DESIGN
Filing DateWednesday, March 30, 2022
Status686 - PUBLISHED FOR OPPOSITION
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements


Goods and ServicesPharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting metabolism; Pharmaceutical agents affecting sensory organs; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for skin care; Pharmaceutical preparations for skin care; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the central nervous system; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the prevention of thrombosis; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of inflammation; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypoglycemia; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, elixirs for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for the treatment of viral diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical skin lotions; Anti-diabetic pharmaceuticals; Anti-epileptic pharmaceutical preparations; Balms for pharmaceutical purposes; Dermatological pharmaceutical products; Digestives for pharmaceutical purposes; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Plant extracts for pharmaceutical purposes; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Yeast for pharmaceutical consumption
NOT AVAILABLE"WELLNESS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFig Life Sciences LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
Addressreno, NV 89502

Party NameFig Life Sciences LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
Addressreno, NV 89502

Trademark Events


Event DateEvent Description
Saturday, January 21, 2023EXAMINERS AMENDMENT -WRITTEN
Saturday, April 2, 2022NEW APPLICATION ENTERED
Tuesday, April 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 13, 2023ASSIGNED TO EXAMINER
Monday, January 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, January 21, 2023EXAMINERS AMENDMENT E-MAILED
Saturday, January 21, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, January 21, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2023OPPOSITION PAPERS RECEIVED AT TTAB
Tuesday, March 28, 2023OPPOSITION INSTITUTED NO. 999999
Wednesday, September 11, 2024OPPOSITION DISMISSED NO. 999999
Wednesday, September 11, 2024OPPOSITION TERMINATED NO. 999999
Wednesday, September 11, 2024TTAB RELEASE CASE TO TRADEMARKS